Microsoft and Bristol Myers Squibb have partnered to improve early detection of lung cancer using AI-powered radiology tools.
Key Details
- 1The collaboration aims to leverage Microsoft's scalable AI imaging platform and BMS’s oncology expertise.
- 2Focus is on optimizing early detection and care pathways for non-small cell lung cancer patients.
- 3Targeted initiatives include addressing low adherence to follow-up and improving workflows for underserved populations.
- 4Lung cancer claims about 125,000 U.S. lives annually, but early diagnosis via low-dose CT reduces mortality risk.
- 5The partnership seeks to deliver scalable diagnostic tools and efficiency gains for healthcare organizations.
Why It Matters
Early lung cancer detection has a clear impact on patient survival, but screening adherence remains low. Integrating scalable AI radiology platforms with oncology expertise could significantly improve workflows, diagnosis, and patient outcomes, especially for underserved populations.
Source
Radiology Business
Related News
•Radiology Business
Stanford AI Lab and Rad Partners Form Alliance to Monitor Imaging AI
Stanford Radiology's AI Lab and Rad Partners announce a partnership to develop and share best practices for assessing and monitoring AI in medical imaging.
•AuntMinnie
AI Analysis of CAC CT Scans Predicts COPD Risk
AI-derived myosteatosis measurements from CAC CT scans predict future COPD, outperforming emphysema-based biomarkers.
•Radiology Business
AI Automates CPT Coding for Interventional Radiology Procedures
Large language models like XLNet show promise in automating CPT code assignment for interventional radiology procedures.